Dr. Devlin is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
721 Glenwood Dr
Ste 467
Chattanooga, TN 37404Phone+1 423-698-3423Fax+1 423-698-1380
Summary
- Dr. Thomas Devlin, MD, PhD., is a neurologist practicing in Chattanooga, TN. He serves the local community in a number of positions that include Director of the National Stroke Prevention Training Center, Chairman of the Department of Neurology at the University Of Tennessee College Of Medicine, and Executive Director of Chattanooga Network for Stroke. As well, Dr. Thomas Devlin, MD, PhD., is active in many national and international health organizations. He is a National Steering Committee Member for Merci Registry Clinical Trials and the International Committee Chairman for New Technology Development for Brainsgate, LLC.
A popular speaker and presenter, Dr. Thomas Devlin, MD, PhD., has lectured at events such as the Regional Nurses and Stroke Team Meeting in Orlando, Florida. Notably, Dr. Thomas Devlin, MD., PhD., was chosen to present his work to President George W. Bush at the Regional Stroke Center at Erlanger Hospital in 2007.
Dr. Thomas Devlin, MD., PhD., has dedicated his career to medicine. He has authored dozens of publications on stroke and is considered one of the nation’s leading experts on neurological disorders. In 2014, Dr. Thomas Devlin, MD. PhD., was bestowed the Outstanding Physician Award from Erlanger Hospital. In 2010, along with Dr. Peter Hunt, Dr. Thomas Devlin, MD, PhD, was formerly recognized by Brainsgate as part of a two physician team to carry out the first successful human implantation of the Sphenopalantine Gangion Stimulator for Acute Ischemic Stroke.
Dr. Thomas Devlin, MD. PhD., is Board Certified by the American Board of Sleep Medicine and the American Board of Neurology and Psychiatry.
Education & Training
- University of Virginia Medical CenterFellowship, Neurocritical Care, 1995 - 1996
- Duke University HospitalResidency, Neurology, 1992 - 1995
- Baylor College of MedicineClass of 1991
- University of Connecticut Health Science CenterPh.D, Neuroscience, 1984 - 1990
Certifications & Licensure
- GA State Medical License 1996 - 2026
- NE State Medical License 2020 - 2026
- NY State Medical License 2020 - 2026
- OH State Medical License 2020 - 2026
- FL State Medical License 2020 - 2025
- IN State Medical License 2020 - 2025
- KY State Medical License 2021 - 2025
- American Board of Psychiatry and Neurology Neurology
- American Board of Psychiatry and Neurology Vascular Neurology
- AOA Board of Neurology and Psychiatry Sleep Medicine (CAQ)
- Join now to see all
Clinical Trials
- Efficacy and Safety Study of GM602 in Patients With Acute Middle Cerebral Artery Ischemic Stroke Within 18 Hours Start of enrollment: 2011 Mar 08
- COOL-ARREST Pilot Study to Assess Intravascular Temperature Management (IVTM) in the Treatment of Cardiac Arrest Start of enrollment: 2014 Jul 01
Publications & Presentations
PubMed
- 1 citationsThe impact of race and ethnicity on acute telestroke care: A multistate experience.Mark McDonald, Theresa Sevilis, Michelle Boudreau, Hsiong Chen, Caitlyn Boyd
Journal of Telemedicine and Telecare. 2025-01-01 - Intravenous Odatroltide for Acute Ischemic Stroke Within 24 Hours of Onset: A Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study.A-Ching Chao, Tsong-Hai Lee, Luther C Pettigrew, Yousef Hannawi, Hung-Yu Huang
Drug Design, Development and Therapy. 2024-01-01 - 2 citationsRobot-Assisted Transcranial Doppler Versus Transthoracic Echocardiography for Right to Left Shunt Detection.Mark N Rubin, Ruchir Shah, Thomas Devlin, Teddy S Youn, Michael F Waters
Stroke. 2023-11-01
Press Mentions
- Large Real-World, Multi-Center Study Demonstrates Viz.ai Platform Saves Critical Minutes in Stroke CareFebruary 8th, 2023
- Early Treatment via Mobile Stroke Units Yields Better Outcomes vs. ‘Drip and Ship’August 5th, 2021
- Lumosa Therapeutics Announces Positive Results from LT3001 Phase 2a Clinical Trial in Acute Ischemic StrokeAugust 3rd, 2021
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: